These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 6606652)

  • 21. Formation of DNA strand breaks by D-penicillamine and bucillamine in human lymphocytes.
    Yamanaka H; Hakoda M; Kamatani N; Kashiwazaki S; Carson DA
    Immunopharmacology; 1993; 26(2):113-8. PubMed ID: 8282535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CuSO4 as an inhibitor of B cell proliferation.
    Yamauchi T; Yamamoto I
    Jpn J Pharmacol; 1990 Dec; 54(4):455-60. PubMed ID: 2087007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Basis of immunosuppressive effect of D-penecillamine].
    Schumacher K
    Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro and in vivo interactions of D-penicillamine with tumors.
    Samoszuk M; Nguyen V
    Anticancer Res; 1996; 16(3A):1219-23. PubMed ID: 8702240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
    Morinobu A; Wang Z; Kumagai S
    J Rheumatol; 2000 Apr; 27(4):851-8. PubMed ID: 10782806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
    Mita S; Matsunaga K
    Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H
    Sciegienka SJ; Solst SR; Falls KC; Schoenfeld JD; Klinger AR; Ross NL; Rodman SN; Spitz DR; Fath MA
    Free Radic Biol Med; 2017 Jul; 108():354-361. PubMed ID: 28389407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
    Starkebaum G; Harlan JM
    J Clin Invest; 1986 Apr; 77(4):1370-6. PubMed ID: 3514679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide.
    Nelson RD; Herron MJ; McCormack RT; Gehrz RC
    Infect Immun; 1984 Mar; 43(3):1041-6. PubMed ID: 6365780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of T cell-dependent antibody production by D-penicillamine. Different requirements for Cu2+ in suppression of polyclonal and antigen-specific B cell responses.
    Petersen J
    Allergy; 1987 Jan; 42(1):37-45. PubMed ID: 3551672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen peroxide-mediated inhibition of T-cell response to mitogens is a result of direct action on T cells.
    Patterson DA; Rapoport R; Patterson MA; Freed BM; Lempert N
    Arch Surg; 1988 Mar; 123(3):300-4. PubMed ID: 3257684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
    Gupte A; Mumper RJ
    Free Radic Biol Med; 2007 Nov; 43(9):1271-8. PubMed ID: 17893040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.
    Seaman WE; Gindhart TD; Blackman MA; Dalal B; Talal N; Werb Z
    J Clin Invest; 1982 Apr; 69(4):876-88. PubMed ID: 7076851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of D-penicillamine on lymphocyte function.
    Schumacher K; Maerker-Alzer G; Preuss R
    Arzneimittelforschung; 1975 Apr; 25(4):603-6. PubMed ID: 125594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.
    Lipsky PE; Ziff M
    J Clin Invest; 1977 Mar; 59(3):455-66. PubMed ID: 838859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.
    Cuthbert JA; Lipsky PE
    J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some immunological effects of penicillamine.
    Chen DM; Di Sabato G; Field L; Gallo AA; Harshman S
    Clin Exp Immunol; 1977 Nov; 30(2):317-22. PubMed ID: 304785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functions.
    el-Hag A; Lipsky PE; Bennett M; Clark RA
    J Immunol; 1986 May; 136(9):3420-6. PubMed ID: 3007617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.
    el-Hag A; Clark RA
    J Immunol; 1987 Oct; 139(7):2406-13. PubMed ID: 2821114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.